Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:

Find A Business
or Browse Listings

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

10.01 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

62 63 Next >

Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks

March 17, 2026

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Vertex Pharmaceuticals (NASD...

Via StockStory

Topics Artificial Intelligence

Winners And Losers Of Q4: Biogen (NASDAQ:BIIB) Vs The Rest Of The Therapeutics Stocks

March 09, 2026

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next ...

Via StockStory

Topics Artificial Intelligence

Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks

March 08, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Amgen (NASDAQ:AMGN) and its p...

Via StockStory

Topics Artificial Intelligence

NOVAVAX INC (NASDAQ:NVAX) Screens as a Minervini-Style High-Growth Momentum Candidate ↗

March 07, 2026

Via Chartmill

MRNA Vs NVAX: Which Vaccine Stock Is Wall Street More Bullish On Right Now? ↗

January 21, 2026

Via Stocktwits

Why Novavax (NVAX) Shares Are Falling Today

February 27, 2026

Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) fell 8.7% in the afternoon session after the release of a key inflation report revealed prices paid to U.S. producers rose more than...

Via StockStory

Topics Artificial Intelligence Economy Supply Chain

The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines

February 27, 2026

As of today, February 27, 2026, the biotech sector is witnessing a dramatic reappraisal of one of its most storied pandemic-era players. Novavax (NASDAQ: NVAX) has surged 17.4% following the release of...

Via Finterra

Topics Economy

Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? ↗

February 27, 2026

Novavax said it is pivoting toward a partnership-led model, including a licensing deal with Pfizer for its Matrix-M technology.

Via Stocktwits

Topics Earnings

NVAX Q4 Deep Dive: Partnership-Led Strategy and Pipeline Transition Shape Outlook

February 27, 2026

Vaccine biotechnology company Novavax (NASDAQ:NVAX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 66.6% year on year to $147.1 million. Its non-GAAP profit of...

Via StockStory

Why Is Novavax (NVAX) Stock Soaring Today

February 26, 2026

Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 24.4% in the morning session after the company reported fourth-quarter financial results that significantly beat analyst...

Via StockStory

Topics Artificial Intelligence Economy

Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue ↗

February 26, 2026

The company generated $147 million in revenue during Q4, a 67% year-on-year (YoY) increase. Earnings per share (EPS) for the quarter were $0.11.

Via Stocktwits

Topics Artificial Intelligence

Novavax (NASDAQ:NVAX) Surprises With Strong Q4 CY2025

February 26, 2026

Via StockStory

Topics Artificial Intelligence

NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash ↗

February 26, 2026

Koyfin analysts expect revenue to grow nearly 28% from the last quarter and forecast losses to narrow significantly.

Via Stocktwits

Novavax (NVAX) Q4 Earnings Report Preview: What To Look For

February 25, 2026

Vaccine biotechnology company Novavax (NASDAQ:NVAX) will be announcing earnings results tomorrow before market open. Here’s what you need to know.

Via StockStory

Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts ↗

February 24, 2026

According to data from Fiscal AI, Novavax is expected to report a quarterly loss per share of $0.55, higher than the loss of $0.52 reported in the corresponding quarter of 2024.

Via Stocktwits

Topics Artificial Intelligence Earnings

3 Small-Cap Stocks We Steer Clear Of

February 22, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

3 of Wall Street’s Favorite Stocks We Approach with Caution

February 16, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

3 Stocks Under $10 with Warning Signs

February 15, 2026

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as...

Via StockStory

Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know

February 13, 2026

A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a...

Via StockStory

Topics Economy

Why Did Moderna Stock Tumble Nearly 10% After Hours Today? ↗

February 10, 2026

The FDA’s CBER issued a refusal-to-file letter for Moderna’s flu vaccine mRNA-1010.

Via Stocktwits

3 Cash-Heavy Stocks That Fall Short

February 01, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Topics Artificial Intelligence

3 Healthcare Stocks We Steer Clear Of

January 29, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also...

Via StockStory

Topics Stocks

This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy? ↗

January 29, 2026

The business may not be as strong as its performance this year suggests.

Via The Motley Fool

Moderna’s 2026 Pivot: From Pandemic Pioneer to Oncology Powerhouse

January 22, 2026

As of January 22, 2026, Moderna, Inc. (NASDAQ: MRNA) finds itself at a pivotal crossroads in its corporate evolution. Once the poster child for the global pandemic response, the Cambridge-based...

Via Finterra

Topics Artificial Intelligence Economy Intellectual Property

Why Are Novavax (NVAX) Shares Soaring Today

January 21, 2026

Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 19.7% in the afternoon session after the company announced it entered into a license agreement with Pfizer for its Matrix-M adjuvant...

Via StockStory

Topics Artificial Intelligence Supply Chain

Why NVAX Stock Is Popping Pre-Market – And What Does Pfizer Have To Do With It? ↗

January 20, 2026

The company signed a licensing agreement with Pfizer, granting it non-exclusive rights to use Matrix-M adjuvant in up to two disease areas.

Via Stocktwits

2 Growth Stocks with Explosive Upside and 1 That Underwhelm

January 15, 2026

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

Via StockStory

Trump’s Iran Tariff Threat Lit a Fuse Under Oil — and Wall Street Still Sold It ↗

January 14, 2026

Via Chartmill

Topics Government

CORRECTED: Why Is Novavax Stock Soaring? ↗

January 13, 2026

Novavax Inc (NASDAQ:NVAX) shares are trading higher. Reports show a rise in respiratory illnesses across the United States.

Via Benzinga

Nasdaq, S&P 500 Futures Wobble As Trump-Powell Clash Rattles Markets: Why CRML, HIMS, WMT, NFLX, NVAX, COF Are On Traders' Radar Today ↗

January 12, 2026

Via Stocktwits

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

62 63 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Novavax, Inc. - Common Stock (NQ:NVAX)

Headline News about Novavax, Inc. - Common Stock